BJUI. Solitary solid renal mass: can we predict malignancy?
|
|
- Amberly Knight
- 5 years ago
- Views:
Transcription
1 BJUI Solitary solid renal mass: can we predict malignancy? Philippe Violette, Samuel Abourbih, Konrad M. Szymanski, Simon Tanguay, Armen Aprikian, Keith Matthews, Fadi Brimo * and Wassim Kassouf Divisions of Urology and *Pathology, McGill University Health Centre, Montreal, QC, Canada Accepted for publication 23 March 2012 P.V. and S.A. contributed equally to this work. W.K. is a recipient of a Research Scholar Award from the FRSQ. Study Type Therapy (retrospective cohort) Level of Evidence 3a OBJECTIVE To determine the clinical predictors of benign disease in patients with solitary solid renal masses. PATIENTS AND METHODS Pathology reports of patients who underwent radical or partial nephrectomy at two hospitals from 1998 to 2008 were reviewed. Only patients with solitary solid unilateral renal masses were included. Predictors of malignancy risk were assessed with univariate and multivariate logistic regression analysis. RESULTS A total of 592 patients with a mean (SD ) age of 60 (13) years were included, 38% of whom were women. Radical and partial nephrectomy was performed in 66% and 34% of patients, respectively. What s known on the subject? and What does the study add? It is known that the majority (80%) of solid renal masses are malignant. Most of the literature suggests that smaller tumour size is associated with a higher incidence of benign disease. We have confirmed that decreased tumour size is associated with benign disease, particularly for lesions < 2 cm. Once radiologically apparent angiomyolipomas are excluded, the incidence of benign disease with small renal masses is lower than reported in the literature (11%). Furthermore, we have shown that small renal masses in females have a higher association with benign disease. Patient age and tumour location were not predictive of benign histology. We have also stratified our risks not only for benign disease but also for clinically indolent renal cancers to help physicians counsel patients with regard to managing these solid renal masses. Renal masses were equally distributed on the right and left sides (49% vs 51%, P = 0.84). Masses were more commonly located in the upper and lower poles than in the mid pole (40.8% vs 38.7% vs 20.5%, respectively). The mean tumour size was larger in patients who underwent radical compared with partial nephrectomy (6.8 cm vs 2.9 cm, P < 0.001). The rate of benign disease in our overall population was 9.5%. On univariate and multivariate analysis, only a renal mass size <2 cm and female gender were predictive of benign disease. On further analysis the magnitude of this effect was found to be additive. CONCLUSIONS Renal masses < 2 cm and female gender were associated with a higher probability of benign disease. Patient age and tumour location were not predictive of benign disease. KEYWORDS renal mass, malignancy, benign, kidney cancer INTRODUCTION Kidney cancer is the seventh most common cancer diagnosis in men, and eighth most common in women in the USA [1 ]. In 2010, an estimated 8200 men will die from kidney cancer. Approximately 60% of kidney cancers are identified incidentally because of the increased use of abdominal imaging [2 ]. Contrast-enhancing kidney masses seen on tomography are considered to be malignant, and in most cases are surgically extirpated without previous tissue diagnosis. Renal masses are traditionally biopsied only when there is suspicion of lymphoma, abscess or extra-renal metastatic disease. Although most masses would be RCC on final pathology, a significant number of these masses may be benign so that patients undergo unnecessary surgery and are subject to its associated morbidity. Our aim was to identify a group of patients that have a higher likelihood of having benign histology, and would hence benefit from further diagnostic testing such as core biopsy, or active surveillance. PATIENTS AND METHODS We retrospectively reviewed the medical records, including pathology reports, of patients who underwent surgical E , E548 E552 doi: /j x x
2 SOLITARY SOLID RENAL MASS: CAN WE PREDICT MALIGNANCY? Population characteristic Gender, n (%) Female 226 (38) Male 366 (62) Mean ( SD ) age, years 60 (13) Histological type: malignant tumours, n (%) 536 Clear-cell 400 (74.6) Papillary 70 (13.1) Chromophobe 46 (8.6) Other * 20 (3.7) Pathological stage: malignant tumour, n (%) pt1a 271 (45.8) pt1b 100 (16.9) pt2a 56 (9.5) pt2b 19 (3.2) pt3a 138 (23.3) pt3b 6 (1) pt4 2 ( <1) Fuhrman grade, n (%) 1 34 (7.7) (56.3) (29.5) 4 29 (6.5) Mean ( SD ) tumour size, cm 5.3 (3.5) Tumour size, n (%) 0 4 cm 293 (49.5) cm 149 (25.2) cm 98 (16.6) > 10 cm 52 (8.8) Tumour location, n (%) Upper 189 (40.8) Lower 179 (38.7) Mid 95 (20.5) TABLE 1 Demographic data for 592 patients *Includes 11 unclassified RCC tumours, three mucinous tubular and spindle-cell carcinomas, one collecting-duct cancer, one angiosarcoma, one metastatic hemangiopericytoma, one tubulocystic RCC, one carcinoid tumour, and one liposarcoma. American Joint Committee on Cancer The absolute number of patients does not add up to 592 owing to missing information. and one third of those were <2 cm. Renal masses were equally distributed on the right and left sides (49% vs 51%, P = 0.84); however they were more commonly located in the upper and lower poles than in the mid pole (40.8% vs 38.7% vs 20.5%, respectively). The mean tumour size in patients who underwent radical compared with partial nephrectomy was 6.8 cm vs 2.9 cm (P < 0.001), respectively. The rate of benign disease in our overall population was 9.5%. Overall, 90.5% of patients had malignant tumours. Of these, 400 (74.6%) were clear-cell RCC, 70 (13.1%) were papillary, 46 (8.6%) were chromophobe, and 20 (3.7%) were miscellaneous other renal malignancies. Of malignant tumours, 64% were Fuhrman grade 1 or 2, and 36% were Fuhrman grades 3 or 4. Perinephric fat invasion was present in 85 (16%) specimens, and six (1%) specimens had vena cava invasion. Oncocytomas were the most common benign lesions occurring in 59% of patients with benign pathology, followed by angiomyolipoma in 25%. Other benign tumours identified were: schwannoma ( n = 1), metanephric adenoma ( n = 1), mesoblastic nephroma ( n = 1), xanthogranulomatous pyelonephritis ( n = 1), hydatid cyst ( n = 1), cystic nephroma ( n = 1), hamartoma ( n = 1) and solitary fibrous tumour ( n = 1). management for solid renal masses that were suspected RCCs. After institutional ethics board approval, data were collected from one academic hospital and one community hospital affiliated with our institution. Inclusion criteria were patients with a solitary solid renal mass who underwent partial or radical nephrectomy, either laparoscopic or open, for suspicion of RCC during the period Exclusion criteria were patients with multiple masses, bilateral masses, cystic masses, or if the solid renal mass was radiologically reported as angiomyolipoma owing to the presence of fat on the preoperative CT. We extracted demographic data for each patient such as age and gender. We also examined tumour characteristics: size of mass (widest diameter), location (upper, mid or lower pole), histology, tumour stage, Fuhrman grade, final margin status and presence of lymphovascular invasion. Proportions were compared using the one-sample proportion test. Continuous variables were compared using the Student s t -test. The Cochran Armitage test for trend was used to evaluate whether renal mass size was related to the risk of malignancy. Predictors of malignancy risk were assessed using univariate and multivariate logistic regression. Statistical analyses were performed using Stata v.10.1 (StataCorp, College Station, TX, USA). RESULTS Baseline demographic data is shown in Table 1. Out of the 651 patients initially identified, 592 met the inclusion criteria and were included in our final analysis. Patients had a mean ( SD ) age of 60 (13) years and 38% were women. Approximately half the tumours were 4 cm in maximum diameter, Using the Cochran Armitage test, initial analysis showed a significant association between smaller tumour size and decreased risk of malignancy ( P = 0.005) (Table 2 ). This trend was even more significant when considering only the risk of high grade malignancy, i.e. Fuhrman score >2 (P < 0.001). We therefore performed a logistic regression analysis to better define this association. On univariate analysis (Table 3 ), tumours were stratified into four size groups: 2 cm, 2.1 to 3 cm, 3.1 to 4 cm and > 4 cm. Tumour size 2 cm was associated with a decreased risk of malignancy (OR 0.39, P = 0.009) compared with larger tumours. Male gender conferred statistically greater odds of having a malignant tumour as compared to females (OR 2.16, P = 0.006). Patients were also stratified into four groups by age: < 50, 50 to 60, 60 to 70, and > 70. None of these groups differed significantly in terms of risk of malignancy. Tumour location (upper, middle or lower pole), or nature of the hospital (academic vs 2012 E549
3 VIOLETTE ET AL. TABLE 2 Risk of malignancy by renal mass size Renal mass size No. of patients (%) Risk of malignancy (%) Risk of high grade (Fuhrman >2) malignancy (%) Total 592 (100.0) 536/592 (90.5) 163/502 (32.5) 4 cm 293 (49.5) 260/293 (88.7) 42/251 (16.7) 2 cm 86 (14.5) 71/86 (82.6)* 10/81 (12.3)** 2 3 cm 112 (18.9) 98/112 (87.5)* 15/93 (16.1)** 3 4 cm 95 (16.1) 91/95 (95.8)* 17/77 (22.1)** >4 cm 299 (50.5) 276/299 (92.3)* 121/251 (48.2)** 4 7 cm 149 (25.2) 135/149 (90.6) 45/121 (37.2) 7 10 cm 98 (16.6) 93/98 (94.9) 49/86 (57.0) > 10 cm 52 (8.8) 48/52 (92.3) 27/44 (61.4) Cochran Armitage test for trend: *P = and * *P < TABLE 3 Variables associated with malignant renal mass ( N = 592) Logistic regression analysis Univariate Multivariate Variable n (%) OR (95% CI) P OR (95% CI) P Tumour size 4 cm 293 (49.5) 2 cm 86 (14.5) 0.39 ( ) * 0.48 ( ) * 2 3 cm 112 (18.9) 0.58 ( ) ( ) cm 95 (16.1) 1.90 ( ) ( ) 0.22 >4 cm 299 (50.5) 1.00 (reference) n/a 1.00 (reference) n/a Right side 299 (50.5) 0.95 ( ) ( ) 0.62 Location Upper pole 189 (31.9) 1.00 (reference) n/a 1.00 (reference) n/a Mid pole 95 (16.1) 0.76 ( ) ( ) 0.63 Lower pole 179 (30.2) 0.87 ( ) ( ) 0.76 Unknown 129 (21.8) 0.49 ( ) ( ) 0.22 Age <50 years 148 (25.0) 0.86 ( ) ( ) years 134 (22.6) 1.88 ( ) ( ) years 161 (27.2) 0.78 ( ) ( ) years 149 (25.2) 1.00 (reference) n/a 1.00 (reference) n/a Male gender 366 (61.8) 2.16 ( ) * 2.13 ( ) 0.01 * Underwent surgery at academic centre 518 (87.5) 1.00 ( ) ( ) 0.78 OR: odds ratio. P values < 0.05 were considered significant and are marked with an asterisk. community), were also nonsignificant in determining risk of malignancy. On multivariate analysis, tumour size <2 cm and female gender were the only variables associated with a decreased risk of malignancy. We did not detect an interaction between significant variables in multivariate analysis ( P = 0.42, data not shown). We then used a multivariate linear regression model to assess the probability of malignant disease by mass size and patient gender to determine whether these factors were additive or synergistic. Table 4 shows an additive relationship of the effect of mass size and gender on probability of malignant disease. Female patients with tumours 2 cm in TABLE 4 Predicted probabilities of malignancy by gender and renal mass size using multivariate linear regression analysis Probability of malignancy % Renal mass All Fuhrman Grades Fuhrman grade > 2 size Female Male Female Male 2 cm cm cm >4 cm size had a 76.8% probability of having a malignancy. Interestingly, if we change the endpoint to predicting clinically indolent disease, defined as benign or less aggressive disease (T1a with Fuhrman grade 2), only tumour size remains a significant predictor of clinically indolent disease. The risk of not having a clinically indolent disease decreased to 12.3% for tumours 2 cm (Tables 2,4 ). DISCUSSION Owing to the widespread use of abdominal imaging, incidentally found renal masses have become increasingly common. Given that a significant percentage of these will be benign, it is important to try to identify risk factors that can correctly predict benign disease. The present study shows that female gender and tumour size 2 cm were independent predictors of benign disease, and that the effect of these two variables were additive in lowering risk. To our knowledge, this is the first report to show such a relationship. Age and tumour location were not associated with benign disease or less aggressive tumours. Our findings concur with previous studies. In a recent retrospective study, Zisman et al. [3 ] showed that female gender was associated with an increased risk of benign histology, with 21% having benign disease compared with 13% of men ( P = 0.001). In another study of 488 cases, women were more likely than men to have benign mass (27.3% vs 14.5%, P < 0.001) [4 ]. In a study of Japanese patients undergoing partial nephrectomy for small renal masses, 26.1% of women had benign lesions compared with 5.4% of men ( P < 0.001) [5 ]. E
4 SOLITARY SOLID RENAL MASS: CAN WE PREDICT MALIGNANCY? While female gender appears to be uniformly protective from malignancy in the literature, the effect of tumour size on malignancy is less clear. In the present study, tumour size <2 cm was associated with a decreased risk of malignancy and there was a significant trend for smaller tumours to be less malignant. This is consistent with other reports [6,7 ]. One study reported a significant correlation between benign histological findings and tumour diameter ( P = 0.017) [6 ]. Another report found that for every 1 cm increase in tumour size, the odds of having RCC as opposed to a benign tumour went up by 17% ( P < 0.001) [7 ]. However, other studies found no significant association between tumour size alone and malignancy risk [3,4,8,9 ]. The present study showed an overall rate of malignancy of 90.5%. This is substantially higher than the 80 85% malignancy rate reported by others [4,10,11 ]. The high malignancy rate in the present study could be attributable to the fact that we excluded tumours diagnosed as angiomyolipomas on preoperative CT scans. This was purposely done to reflect real-life practice where smaller lesions, which are reported as angiomyolipoma owing to the presence of gross fat on CT, are typically followed without intervention. Furthermore, being a referral centre, urologists at our institution are likely to see a high proportion of complex cases, which are more likely be malignant. Based on the present results, 23.2% of women with small tumours 2 cm will have benign disease on pathology. This finding implies that 1 in 4 would have been exposed to potential morbidity from surgery unnecessarily. One can speculate whether these patients may benefit from further investigation, such as a core needle biopsy. Significant strides have been made recently in improving the accuracy and safety of biopsies. Older techniques, which employed fine needle aspiration had suboptimum sensitivities whereas newer techniques, employing core biopsies have shown low false-negative rates [12,13 ] ; therefore, greater consideration could be given to obtaining tissue diagnosis before surgery for women with small tumours. An alternative approach to upfront surgery is active surveillance of small tumours. We, and others, have shown that selected patients with small renal masses can be safely followed [14,15 ]. In a recent metaanalysis, Chawla et al. [16 ] examined the outcome of 234 observed small renal masses after a mean duration of 34 months. The mean lesion size at presentation was 2.6 cm with a mean rate of growth of 0.28 cm/year. There were only three documented reports of metastases, one in a patient with a rapidly growing tumour and one in a patient with a 9-cm initial sized tumour. Specific information regarding the third patient who developed metastatic disease is absent from the original report. In a recent article by Jewett et al. [17 ], 178 patients were followed prospectively with biopsies and serial imaging to determine the rate of progression and metastases in patients with small renal masses ( 4 cm maximum tumour diameter). Out of the 127 patients included in the growth analysis, 25 progressed locally and two developed metastases. The rates of growth of benign and malignant lesions were not significantly different. These articles lend further support to the hypothesis that small renal masses grow slowly with rare metastases. Combining this information with results from the present study suggests that active surveillance may be even more advocated for elderly women with small renal masses (especially those 2 cm) as they have the highest probability of harbouring benign or clinically indolent disease. Lastly, unlike the authors of other studies, we did not find an association between age and incidence of benign disease or less aggressive tumours. The strengths of the present study include its large sample size and its multifaceted nature, encompassing multiple surgeons in both academic and community practices. In addition, the present analysis included clinically relevant, readily available baseline patient and tumour characteristics. It also reflected real-life practice in that it excluded lesions that are reported as angiomyolipoma owing to the presence of gross fat on CT as patients with such lesions are typically followed without intervention. The present study was limited by being retrospective with inherent associated biases. In addition, we used pathological specimen dimensions to quantify tumour size. This probably underestimated the actual size of the masses in vivo, because formalin fixation causes tumours to shrink. This fact is noteworthy because in previous studies looking at non-small cell lung cancer, formalin had been shown to cause sufficient shrinkage such that there was stage migration in a minority of tumours [18 ]. The malignancy rates we obtained, based on dimensions from pathological specimens, could theoretically be different from those from CT-based measurements; however, as Kurta et al. [19 ] have shown, the difference between pathological and CT sizing of renal masses is, at most, a few mm, and hence not clinically significant. We believe the present results would therefore also be applicable to renal masses measured by tomography. Finally, whether specific preoperative imaging characteristics (such as degree of enhancement, presence of central scar, etc.) can predict malignant histology requires further evaluation. In conclusion, small incidentally found renal masses pose a challenge to urologists because many of these tumours are either benign or have less aggressive biology. We have identified a subgroup of patients, namely females with tumours <2 cm who have significantly reduced odds of having malignant tumours. Those odds decrease further when we exclude tumours of less aggressive biology. The option of renal biopsy and active surveillance could therefore be more strongly advocated for this patient population. CONFLICT OF INTEREST None declared. Source of funding: Le fonds de la recherche en Sant é du Qu é bec. REFERENCES 1 Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, CA Cancer J Clin ; 60 : Jayson M, Sanders H. Increased incidence of serendipitously discovered renal cell carcinoma. Urology 1998 ; 51 : Zisman A, Patard JJ, Raz O et al. Sex, age, and surgeon decision on nephron-sparing surgery are independent predictors of renal masses with benign histologic findings a multicenter survey. Urology 2010 ; 76 : DeRoche T, Walker E, Magi-Galluzzi C, 2012 E551
5 VIOLETTE ET AL. Zhou M. Pathologic characteristics of solitary small renal masses: can they be predicted by preoperative clinical parameters? Am J Clin Pathol 2008 ; 130 : Fujii Y, Komai Y, Saito K et al. Incidence of benign pathologic lesions at partial nephrectomy for presumed RCC renal masses: Japanese dual-center experience with 176 consecutive patients. Urology 2008 ; 72 : Murphy AM, Buck AM, Benson MC, McKiernan JM. Increasing detection rate of benign renal tumors: evaluation of factors predicting for benign tumor histologic features during past two decades. Urology 2009 ; 73 : Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol 2003 ; 170 : Remzi M, Ozsoy M, Klingler HC et al. Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter. J Urol 2006 ; 176 : Jeon HG, Lee SR, Kim KH et al. Benign lesions after partial nephrectomy for presumed renal cell carcinoma in masses 4 cm or less: prevalence and predictors in Korean patients. Urology 2010 ; 76 : Lane BR, Babineau D, Kattan MW et al. A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy. J Urol 2007 ; 178 : Schlomer B, Figenshau RS, Yan Y, Venkatesh R, Bhayani SB. Pathological features of renal neoplasms classified by size and symptomatology. J Urol 2006 ; 176 : ; discussion Leveridge MJ, Finelli A, Kachura JR et al. Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy. Eur Urol 2011 ; 60 : Volpe A, Kachura JR, Geddie WR et al. Techniques, safety and accuracy of sampling of renal tumors by fine needle aspiration and core biopsy. J Urol 2007 ; 178 : Kassouf W, Aprikian AG, Laplante M, Tanguay S. Natural history of renal masses followed expectantly. J Urol 2004 ; 171 : ; discussion Abou Youssif T, Kassouf W, Steinberg J, Aprikian AG, Laplante MP, Tanguay S. Active surveillance for selected patients with renal masses: updated results with long-term follow-up. Cancer 2007 ; 110 : Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 2006 ; 175 : Jewett MA, Mattar K, Basiuk J et al. Active surveillance of small renal masses: progression patterns of early stage kidney cancer. Eur Urol 2011 ; 60 : Hsu PK, Huang HC, Hsieh CC et al. Effect of formalin fixation on tumor size determination in stage I non-small cell lung cancer. Ann Thorac Surg 2007 ; 84 : Kurta JM, Thompson RH, Kundu S et al. Contemporary imaging of patients with a renal mass: does size on computed tomography equal pathological size? BJU Int 2009 ; 103 : 24 7 Correspondence: Wassim Kassouf, Assistant Professor of Urology, McGill University Health Centre, Montreal General Hospital, 1650 Cedar Ave. L8-315, Montreal, Quebec, Canada H3G 1A4. wassim.kassouf@muhc.mcgill.ca E
Pathologic Characteristics of Solitary Small Renal Masses. Can They Be Predicted by Preoperative Clinical Parameters?
Anatomic Pathology / Pathology of Small Renal Masses Pathologic Characteristics of Solitary Small Renal Masses Can They Be Predicted by Preoperative Clinical Parameters? Tom DeRoche, MD, 1 Esteban Walker,
More informationDiagnostic accuracy of percutaneous renal tumor biopsy May 10 th 2018
Diagnostic accuracy of percutaneous renal tumor biopsy May 10 th 2018 Dr. Tzahi Neuman Dep.Of Pathology Hadassah Medical Center Jerusalem, Israel, (tneuman@hadassah.org.il) Disclosure: 1 no conflicts of
More informationWHAT IS THE ROLE OF ACTIVE SURVEILLANCE
WHAT IS THE ROLE OF ACTIVE SURVEILLANCE IN THE CONTEXT OF RENAL ABLATION AND PARTIAL NEPHRECTOMY? Alessandro Volpe University of Eastern Piedmont Novara, Italy RCC INCIDENCE SEER DATABASE (1975-2006) RCC
More informationBJUI. Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy
BJUI Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy Nilay Patel, David Cranston, M. Zeeshan Akhtar, Caroline George, Andrew
More informationRenal Mass Biopsy: Needed Now More than Ever
Renal Mass Biopsy: Needed Now More than Ever Stuart G. Silverman, MD, FACR Professor of Radiology Harvard Medical School Director, Abdominal Imaging and Intervention Brigham and Women s Hospital Boston,
More informationComparison of radiographic and pathologic sizes of renal tumors
ORIGINAL Article Vol. 39 (2): 189-194, March - April, 2013 doi: 10.1590/S1677-5538.IBJU.2013.02.06 Comparison of radiographic and pathologic sizes of renal tumors Wei Chen, Linhui Wang, Qing Yang, Bing
More informationCanadian Guidelines for Management of the Small Renal Mass (SRM)
Canadian Guidelines for Management of the Small Renal Mass (SRM) Michael A.S. Jewett*, Ricardo Rendon, Louis Lacombe, Pierre I. Karakiewicz, Simon Tanguay, Wes Kassouf, Mike Leveridge, Ilias Cagiannos,
More informationRenal biopsy is mandatory for every small renal mass
Renal biopsy is mandatory for every small renal mass Ben Challacombe Consultant Urologist The Urology Centre Guy s and St. Thomas Hospital NHS Foundation Trust Oncocytoma High Risk Partial converted to
More informationReview Article Surveillance for the Management of Small Renal Masses
Hindawi Publishing Corporation Advances in Urology Volume 2008, Article ID 196701, 6 pages doi:10.1155/2008/196701 Review Article Surveillance for the Management of Small Renal Masses Mehmet Ozsoy, Tobias
More informationWhat is the role of partial nephrectomy in the context of active surveillance and renal ablation?
What is the role of partial nephrectomy in the context of active surveillance and renal ablation? Dogu Teber Department of Urology University Hospital Heidelberg Coming from Heidelberg obligates to speak
More informationTumor necrosis is a strong predictor for recurrence in patients with pathological T1a renal cell carcinoma
ONCOLOGY LETTERS 9: 125-130, 2015 Tumor necrosis is a strong predictor for recurrence in patients with pathological T1a renal cell carcinoma KEIICHI ITO 1, KENJI SEGUCHI 1, HIDEYUKI SHIMAZAKI 2, EIJI TAKAHASHI
More informationRadical Nephrectomy for Renal Cell Carcinoma Its Contemporary Role Related to Histologic Type, Tumor Size, and Nodal Status: A Retrospective Study
AJCP /ORIGINAL ARTICLE Radical Nephrectomy for Renal Cell Carcinoma Its Contemporary Role Related to Histologic Type, Tumor Size, and Nodal Status: A Retrospective Study Kamran M. Mirza, MD, PhD, Jerome
More informationRenal Masses in Patients with Known Extrarenal Primary Primary Cancer Primary Primary n Met Mets s RCC Beni L mphoma Lung Breast Others
The Importance of Stuart G. Silverman, MD, FACR Professor of Radiology Harvard ard Medical School Director, Abdominal Imaging and Intervention Brigham and Women s Hospital Boston, MA The Importance of
More informationSt. Dominic s Annual Cancer Report Outcomes
St. Dominic s 2017 Annual Cancer Report Outcomes Cancer Program Practice Profile Reports (CP3R) St. Dominic s Cancer Committee monitors and ensures that patients treated at St. Dominic Hospital receive
More informationReview Article Small Renal Masses: Incidental Diagnosis, Clinical Symptoms, and Prognostic Factors
Hindawi Publishing Corporation Advances in Urology Volume 2008, Article ID 310694, 6 pages doi:10.1155/2008/310694 Review Article Small Renal Masses: Incidental Diagnosis, Clinical Symptoms, and Prognostic
More informationPatient Selection for Surgery in RCC with Thrombus. E. Jason Abel, M.D.
Patient Selection for Surgery in RCC with Thrombus E. Jason Abel, M.D. RCC with venous invasion Venous invasion occurs in ~10% of RCC Surgery more complex Increased risk for morbidity Thrombus may be confined
More informationClinical Study The Role of Pathology in Small Renal Mass Laparoscopic Cryoablation
Advances in Urology Volume 2012, Article ID 539648, 6 pages doi:10.1155/2012/539648 Clinical Study The Role of Pathology in Small Renal Mass Laparoscopic Cryoablation B. W. Lagerveld, 1 H. van Dekken,
More informationRenal Mass Biopsy Should be Used for Most SRM - PRO
Renal Mass Biopsy Should be Used for Most SRM - PRO Tony Finelli, MD, MSc, FRCSC Head, Division of Urology GU Site Lead, Princess Margaret Cancer Center GU Cancer Lead, Cancer Care Ontario Associate Professor,
More informationGUIDELINES ON RENAL CELL CARCINOMA
GUIDELINES ON RENAL CELL CARCINOMA B. Ljungberg (chairman), D.C. Hanbury, M.A. Kuczyk, A.S. Merseburger, P.F.A. Mulders, J-J. Patard, I.C. Sinescu Introduction This EAU guideline was prepared to help urologists
More informationDIAGNOSTIC SLIDE SEMINAR: PART 1 RENAL TUMOUR BIOPSY CASES
DIAGNOSTIC SLIDE SEMINAR: PART 1 RENAL TUMOUR BIOPSY CASES Dr. Andrew J. Evans MD, PhD, FACP, FRCPC Consultant in Genitourinary Pathology University Health Network, Toronto, ON Case 1 43 year-old female,
More informationCanadian Urological Association guidelines for followup of patients after treatment of nonmetastatic
Canadian Urological Association guidelines for followup of patients after treatment of nonmetastatic renal cell carcinoma Wassim Kassouf, Leonardo L. Monteiro, Darrel E. Drachenberg, Adrian S. Fairey,
More informationResearch Article Practice Trends in the Surgical Management of Renal Tumors in an Academic Medical Center in the Past Decade
ISRN Endoscopy Volume 2013, Article ID 945853, 5 pages http://dx.doi.org/10.5402/2013/945853 Research Article Practice Trends in the Surgical Management of Renal Tumors in an Academic Medical Center in
More informationPathological nature of renal tumors does size matter?
Original Article Pathological nature of renal tumors does size matter? Lutfi Ali S. Kurban, Alireza Vosough 1, Preman Jacob 2, Deepak Prasad 3, Thomas Lam 4, Neil Scott 5, Bhaskar K. Somani 6 Department
More informationDebate: Lymphadenectomy is Important in mrcc, CON P. Mulder, M.D., Ph.D. JJ. Patard, MD, Ph.D.
Debate: Lymphadenectomy is Important in mrcc, CON P. Mulder, M.D., Ph.D. JJ. Patard, MD, Ph.D.. Eighth European International Kidney Cancer Symposium Budapest 03-04 May 2013 The role of LND In organ confined
More informationContemporary Role of Renal Mass Biopsy
Contemporary Role of Renal Mass Biopsy Jeffrey K. Mullins, MD Director Urologic Oncology CHI Memorial Chattanooga Urology Associates September 8, 2018 Disclosures I, Jeffrey Mullins, do not have a financial
More informationFollow-up imaging after nephrectomy for cancer in Canada: urologists compliance with guidelines. An observational study
Follow-up imaging after nephrectomy for cancer in Canada: urologists compliance with guidelines. An observational study Alice Dragomir PhD, Armen Aprikian MD, Anil Kapoor MD, Antonio Finelli MD, Frédéric
More information(2/3 PRCC!) (2/3 PRCC!)
Approach to the Incidental Solid Renal Mass Stuart G. Silverman, MD, FACR Professor of Radiology Harvard ard Medical School Director, Abdominal Imaging and Intervention Brigham and Women s Hospital Boston,
More informationGuidelines on Renal Cell
Guidelines on Renal Cell Carcinoma (Text update March 2009) B. Ljungberg (Chairman), D.C. Hanbury, M.A. Kuczyk, A.S. Merseburger, P.F.A. Mulders, J-J. Patard, I.C. Sinescu Introduction Renal cell carcinoma
More informationWho are Candidates for Laparoscopic or Open Radical Nephrectomy. Arieh Shalhav
Who are Candidates for Laparoscopic or Open Radical Nephrectomy Arieh Shalhav Fritz Duda Chair of Urologic Surgery Professor of Surgery and the Comprehensive Cancer Research Center Who are Candidates for
More informationThe Incidental Renal Mass in the Primary Care Setting
The Incidental Renal Mass in the Primary Care Setting Adele M. Caruso, MSN, CRNP Adult Nurse Practitioner The Perelman School of Medicine at the University of Pennsylvania Abstract There are approximately
More informationACTIVE SURVEILLANCE FOR RENAL MASSES: Where are we in 2016?
ACTIVE SURVEILLANCE FOR RENAL MASSES: Where are we in 2016? Phillip M. Pierorazio, MD Assistant Professor of Urology and Oncology Brady Urological Institute Sidney Kimmel Cancer Center Johns Hopkins Hospital
More informationIndications For Partial
Indications For Partial Nephrectomy Christopher G. Wood, M. D., FACS Professor and Deputy Chairman Douglas E. Johnson, M. D. Endowed Professorship in Urology Department of Urology The University of Texas
More informationPrognostic factors in localized renal cell cancer
Original Article PROGNOSTIC FACTORS IN LOCALIZED RENAL CELL CANCER KNIGHT and STADLER Prognostic factors in localized renal cell cancer David A. Knight and Walter M. Stadler Section of Hematology/Oncology,
More informationIs renal cryoablation becoming an effective alternative to partial nephrectomy?
Is renal cryoablation becoming an effective alternative to partial nephrectomy? J GARNON 1, G TSOUMAKIDOU 1, H LANG 2, A GANGI 1 1 department of interventional radiology 2 department of urology University
More informationRenal Parenchymal Neoplasms
Renal Parenchymal Neoplasms د. BENIGN TUMORS : Benign renal tumors include adenoma, oncocytoma, angiomyolipoma, leiomyoma, lipoma, hemangioma, and juxtaglomerular tumors. Renal Adenomas : The adenoma is
More informationJ Clin Oncol 28: by American Society of Clinical Oncology INTRODUCTION
VOLUME 28 NUMBER 2 JANUARY 0 200 JOURNAL OF CLINICAL ONCOLOGY O R I G I N A L R E P O R T Evaluating Overall Survival and Competing Risks of Death in Patients With Localized Renal Cell Carcinoma Using
More informationActive surveillance for clinically localized renal tumors: An updated review of current indications and clinical outcomes
bs_bs_banner International Journal of Urology (2015) 22, 432 438 doi: 10.1111/iju.12734 Review Article Active surveillance for clinically localized renal tumors: An updated review of current indications
More informationCancer. Description. Section: Surgery Effective Date: October 15, 2016 Subsection: Original Policy Date: September 9, 2011 Subject:
Subject: Saturation Biopsy for Diagnosis, Last Review Status/Date: September 2016 Page: 1 of 9 Saturation Biopsy for Diagnosis, Description Saturation biopsy of the prostate, in which more cores are obtained
More informationThe Incidental Renal lesion
The Incidental Renal lesion BACKGROUND Increase in abdominal CT/US in last 15 years Resulted in detection of many (small) renal lesions 50% > 50yrs has at least 1 lesion majority simple cysts Renal lesions
More informationRENAL CANCER GUIDELINES
Greater Manchester and Cheshire Cancer Network RENAL CANCER GUIDELINES Agreed by Urology CSG: July 2010 Review Date: July 2012 Renal Cancer Guidelines 1. Introduction 1.1 Kidney cancer accounts for 3%
More informationIncidentally detected. small renal masses. Investigation and management. Urology
Urology Incidentally detected Kantha Rao Peter L Royce small renal masses Investigation and management Background With increasing use of imaging to diagnose other conditions, incidentally detected small
More informationRapid communication chronic renal insufficiency after laparoscopic partial nephrectomy and radical nephrectomy for pathologic T1a lesions
Washington University School of Medicine Digital Commons@Becker Open Access Publications 2008 Rapid communication chronic renal insufficiency after laparoscopic partial nephrectomy and radical nephrectomy
More informationKidney Case 1 SURGICAL PATHOLOGY REPORT
Kidney Case 1 Surgical Pathology Report February 9, 2007 Clinical History: This 45 year old woman was found to have a left renal mass. CT urography with reconstruction revealed a 2 cm medial mass which
More informationPatient Selection for Ablative Therapies. Adrian D Joyce Leeds UK
Patient Selection for Ablative Adrian D Joyce Leeds UK Therapy Renal Cell Ca USA: 30,000 new cases annually >12,000 deaths RCC accounts for 3% of all adult malignancy 40% of patients will die from their
More informationLymphadenectomy in RCC: Yes, No, Clinical Trial?
Lymphadenectomy in RCC: Yes, No, Clinical Trial? Viraj Master MD PhD FACS Professor Associate Chair for Clinical Affairs and Quality Director of Clinical Research Unit Department of Urology Emory University
More informationGuidelines for the Management of Renal Cancer West Midlands Expert Advisory Group for Urological Cancer
Guidelines for the Management of Renal Cancer West Midlands Expert Advisory Group for Urological Cancer West Midlands Clinical Networks and Clinical Senate Coversheet for Network Expert Advisory Group
More informationGUIDELINES ON RENAL CELL CANCER
20 G. Mickisch (chairman), J. Carballido, S. Hellsten, H. Schulze, H. Mensink Eur Urol 2001;40(3):252-255 Introduction is characterised by a constant rise in incidence over the last 50 years, with a predominance
More informationMetastatic Potential in Renal Cell Carcinomas =7 cm: Swedish Kidney Cancer Quality Register Data
EUROPEAN UROLOGY 60 (2011) 975 982 available at www.sciencedirect.com journal homepage: www.europeanurology.com Platinum Priority Kidney Cancer Editorial by Eric C. Umbreit and R. Houston Thompson on pp.
More informationconcordance indices were calculated for the entire model and subsequently for each risk group.
; 2010 Urological Oncology ACCURACY OF KATTAN NOMOGRAM KORETS ET AL. BJUI Accuracy of the Kattan nomogram across prostate cancer risk-groups Ruslan Korets, Piruz Motamedinia, Olga Yeshchina, Manisha Desai
More informationAnatomic Features of Enhancing Renal Masses Predict Malignant and High-Grade Pathology: A Preoperative Nomogram Using the RENAL Nephrometry Score
EUROPEAN UROLOGY 60 (2011) 241 248 available at www.sciencedirect.com journal homepage: www.europeanurology.com Platinum Priority Kidney Cancer Editorial by Brian F. Chapin and Christopher G. Wood on pp.
More informationUrological Tumours 1 Kidney tumours 2 Bladder tumours
Urological Tumours 1 Kidney tumours 2 Bladder tumours Tim Bracey SpR Histopathology Derriford Hospital Kidney tumours What are we going to talk about?! Anatomy of urinary tract! Types of kidney tumours!
More informationPartial Nephrectomy Is Associated with Improved Overall Survival Compared to Radical Nephrectomy in Patients with Unanticipated Benign Renal Tumours
EUROPEAN UROLOGY 58 (2010) 293 298 available at www.sciencedirect.com journal homepage: www.europeanurology.com Kidney Cancer Partial Nephrectomy Is Associated with Improved Overall Survival Compared to
More informationEUROPEAN UROLOGY 61 (2012)
EUROPEAN UROLOGY 61 (2012) 1156 1161 available at www.sciencedirect.com journal homepage: www.europeanurology.com Platinum Priority Kidney Cancer Editorial by Alvin C. Goh and Inderbir S. Gill on pp. 1162
More informationBilateral Renal Angiomyolipomas with Invasion of the Renal Vein: A Case Report
Case Study TheScientificWorldJOURNAL (2008) 8, 145 148 TSW Urology ISSN 1537-744X; DOI 10.1100/tsw.2008.29 Bilateral Renal Angiomyolipomas with Invasion of the Renal Vein: A Case Report C. Blick, N. Ravindranath,
More informationEUROPEAN UROLOGY 57 (2010)
EUROPEAN UROLOGY 57 (2010) 661 666 available at www.sciencedirect.com journal homepage: www.europeanurology.com Kidney Cancer Hybrid Renal Cell Carcinomas Containing Histopathologic Features of Chromophobe
More informationThe new TNM staging for renal cell carcinoma: what and why the urologists want to know.
The new TNM staging for renal cell carcinoma: what and why the urologists want to know. Poster No.: C-1132 Congress: ECR 2011 Type: Educational Exhibit Authors: Y. Y. Lim, A. Hattab, A. Bradley ; Manchester/UK,
More informationNAACCR Webinar Series 1
NAACCR 2009 2010 Webinar Series Collecting Cancer Data: Kidney 1 Questions Please use the Q&A panel to submit your questions Send questions to All Panelist 2 Fabulous Prizes 3 NAACCR 2009 2010 Webinar
More informationRAPN. in T1b Renal Masses? A. Mottrie. G. Denaeyer, P. Schatteman, G. Novara
RAPN in T1b Renal Masses? A. Mottrie G. Denaeyer, P. Schatteman, G. Novara Department of Urology O.L.V. Clinic Aalst OLV Vattikuti Robotic Surgery Institute Aalst Belgium Guidelines on Renal Cell Carcinoma
More informationAUA Guidelines Renal Mass and Localized Kidney Cancer
AUA Guidelines Renal Mass and Localized Kidney Cancer Steven C. Campbell, MD, PhD Chair AUA Guidelines Panel Professor Surgery, Vice Chair, Program Director Department of Urology Glickman Urological and
More informationSurgically Discovered Xanthogranulomatous Pyelonephritis Invading Inferior Vena Cava with Coexisting Renal Cell Carcinoma
Case Study TheScientificWorldJOURNAL (2009) 9, 5 9 TSW Urology ISSN 1537-744X; DOI 10.1100/tsw.2009.6 Surgically Discovered Xanthogranulomatous Pyelonephritis Invading Inferior Vena Cava with Coexisting
More informationPercutaneous Biopsy of the Renal Mass: Fine Needle Aspiration or Core Biopsy?
Percutaneous Biopsy of the Renal Mass: Fine Needle Aspiration or Core Biopsy? 1 Chi-Shun Yang, MD, 2 Euna Choi, MD, 2 Muhammad Idrees, MD, 2 Shaoxiong Chen, MD, PhD, and 2 Howard H Wu, MD 1 Department
More informationPartial Nephrectomy Planning: Everybody s s doing it, you can to
Partial Nephrectomy Planning: Everybody s s doing it, you can to Brian R. Herts, MD Associate Professor of Radiology Head, Abdominal Imaging, Imaging Institute & Staff, The Glickman Urological and Kidney
More informationVincenzo Ficarra 1,2,3. Associate Editor BJU International
Partial Nephrectomy for RCC Vincenzo Ficarra 1,2,3 1 Director Department of Urology University of Udine, Italy 2 Associate Editor BJU International 3 Scientific Director OLV Robotic Surgery Institute,
More informationHyperechoic renal masses
Hyperechoic renal masses Jean-Yves Meuwly, MD Department of Diagnostic and Interventional Radiology, University Hospital Lausanne, Switzerland Department of Diagnostic and Interventional Radiology Renal
More informationConcurrent Multilocular Cystic Renal Cell Carcinoma and Leiomyoma in the Same Kidney: Previously Unreported Association
218 Concurrent Multilocular Cystic Renal Cell Carcinoma and Leiomyoma in the Same Kidney: Previously Unreported Association Min Su Cheong a Dong Hun Koo a In-Sung Kim a Kyung Chul Moon b Ja Hyeon Ku a
More informationMay-Lin Wilgus. A. Study Purpose and Rationale
Utility of a Computer-Aided Diagnosis Program in the Evaluation of Solitary Pulmonary Nodules Detected on Computed Tomography Scans: A Prospective Observational Study May-Lin Wilgus A. Study Purpose and
More informationSAMPLING OF POST NEPHRECTOMY CANCER CARE (5)
SAMPLING OF POST NEPHRECTOMY CANCER CARE (5) Universally recognized post-nephrectomy cancer treatment. Sampling: National Comprehensive Cancer Network (NCCN) NCCN Clinical Practice Guidelines in Oncology
More informationThe diagnostic criteria of multilocular renal cysts
Case Report 772 Multilocular Renal Cysts with Renal Cell Carcinoma: Report of Four Cases Chia-Hsi Chen, MD; Cheng-Keng Chuang, MD, PhD; Chun-Te Wu, MD; Kwai-Fong Ng 1, MD; Shuen-Kuei Liao 2, PhD According
More informationMetachronic solitary breast metastasis from renal cell carcinoma: case report
Metachronic solitary breast metastasis from renal cell carcinoma: case report Abstract We describe the case of a patient with solitary and metachronic breast metastasis, 3 years after nephrectomy for renal
More informationRole of computed tomography-calculated intraparenchymal tumor volume in assessment of patients undergoing partial nephrectomy
International Journal of Urology (2018) 25, 436--441 doi: 10.1111/iju.13531 Original Article: Clinical Investigation Role of computed tomography-calculated intraparenchymal tumor volume in assessment of
More informationManchester Cancer. Guidelines for the management of renal cancer
Guidelines for the management of renal cancer Approved by the urology pathway board September 2014 To be reviewed September 2016 Renal Cancer Guidelines 1. Introduction 1.1 Kidney cancer accounts for 3%
More informationManagement, pathology and outcomes of Bosniak category IIF and III cystic renal lesions
World J Urol (2015) 33:295 300 DOI 10.1007/s00345-014-1301-x ORIGINAL ARTICLE Management, pathology and outcomes of Bosniak category IIF and III cystic renal lesions Peter Weibl Milan Hora Boris Kollarik
More informationTreatment of Patients With Small Renal Masses: A Survey of the American Urological Association
Treatment of Patients With Small Renal Masses: A Survey of the American Urological Association Rodney H. Breau,*, Paul L. Crispen,* Sarah M. Jenkins, Michael L. Blute and Bradley C. Leibovich From the
More informationInternational Journal of Scientific & Engineering Research, Volume 6, Issue 2, February ISSN
International Journal of Scientific & Engineering Research, Volume 6, Issue 2, February-2015 1541 OPEN NEPHRECTOMY: A SEVEN- YEAR EXPERIENCE IN UNIVERSITY OF MAIDUGURI TEACHING HOSPITAL NORTH EASTERN NIGERIA
More informationPresentation of Cases /Audience Voting/Panel/Discussion
Presentation of Cases /Audience Voting/Panel/Discussion JJ Patard Tim O Brien Ninth European International Kidney Cancer Symposium Dublin 25-26 April 2014 Clinical case 1 63 years old women Medical past
More informationMANAGEMENT RECOMMENDATIONS
1 MANAGEMENT RECOMMENDATIONS 1. Adrenal masses!!!!!!! page 2 2. Liver Masses!!!!!!! page 3 3. Obstetric US Soft Markers for Aneuploidy!! pages 4-6 4. Ovarian and Adnexal Cysts!!!!! pages 7-10 5. Pancreatic
More informationRCC in ADPKD / CKD / ESRD
RCC in ADPKD / CKD / ESRD FOIU 2018 David A. Goldfarb, MD,FACS Professor of Surgery, Cleveland Clinic Lerner College of Medicine Glickman Urological and Kidney Institute Cleveland Clinic, Cleveland, Ohio
More informationDiagnostic Accuracy of Computed Tomography-Guided Percutaneous Biopsy of Renal Masses
european urology 53 (2008) 1003 1012 available at www.sciencedirect.com journal homepage: www.europeanurology.com Kidney Cancer Diagnostic Accuracy of Computed Tomography-Guided Percutaneous Biopsy of
More informationRole of imaging in RCC. Ultrasonography. Solid lesion. Cystic RCC. Solid RCC 31/08/60. From Diagnosis to Treatment: the Radiologist Perspective
Role of imaging in RCC From Diagnosis to Treatment: the Radiologist Perspective Diagnosis Staging Follow up Imaging modalities Limitations and pitfalls Duangkamon Prapruttam, MD Department of Therapeutic
More informationKey Words: kidney; carcinoma, renal cell; renal insufficiency; nephrectomy; mortality
Comparative Effectiveness for Survival and Renal Function of Partial and Radical Nephrectomy for Localized Renal Tumors: A Systematic Review and Meta-Analysis Simon P. Kim, R. Houston Thompson, Stephen
More informationUrinary Collecting System Invasion is an Independent Prognostic. Factor in Organ Confined Renal Cell Carcinomas.
Author manuscript, published in "Journal of Urology The 2009;182(3):854-9" DOI : 10.1016/j.juro.2009.05.017 Urinary Collecting System Invasion is an Independent Prognostic Factor in Organ Confined Renal
More informationIntroduction. Original Article
bs_bs_banner International Journal of Urology (2015) 22, 363 367 doi: 10.1111/iju.12704 Original Article Prostate-specific antigen level, stage or Gleason score: Which is best for predicting outcomes after
More informationSmall Renal Mass Guidelines. Clif Vestal, MD USMD Arlington, Texas
Small Renal Mass Guidelines Clif Vestal, MD USMD Arlington, Texas Evaluation/Diagnosis 1. Obtain high quality, multiphase, cross-sectional abdominal imaging to optimally characterize/stage the renal mass.
More informationImpact of lymphadenectomy in management of renal cell carcinoma
Journal of the Egyptian National Cancer Institute (2012) 24, 57 61 Cairo University Journal of the Egyptian National Cancer Institute www.nci.cu.adu.eg www.sciencedirect.com ORIGINAL ARTICLE Impact of
More informationPercutaneous Renal Cryoablation After Partial Nephrectomy: Technical Feasibility, Complications and Outcomes
Percutaneous Renal Cryoablation After Partial Nephrectomy: Technical Feasibility, Complications and Outcomes Ryan M. Hegg, Grant D. Schmit,* Stephen A. Boorjian, Robert J. McDonald, A. Nicholas Kurup,
More informationOptimal Treatment of ct1b Renal Mass in Patient with Normal GFR: a Role for Radical Nephrectomy?
Optimal Treatment of ct1b Renal Mass in Patient with Normal GFR: a Role for Radical Nephrectomy? Steven C. Campbell, MD, PhD Program Director, Vice Chairman Department of Urology Center for Urologic Oncology
More informationBaker Alabbadi MD*, Ali Alasmar MD*, Ayman Alqarallah MD*, Nizar Saaydah MD* ABSTRACT
Renal Cell Carcinoma Clinical Presentation and Histopathological Findings: A Retrospective Analysis of a Jordanian Population at King Hussein Medical Center Baker Alabbadi MD*, Ali Alasmar MD*, Ayman Alqarallah
More informationComplex case Presentations
Complex case Presentations Case Presentations April 2016 Lisa M Pickering Case presentations: chromophobe renal carcinoma 60 year old man. ECOG PS 0 No significant comorbodities August 2009: L radical
More informationRepeat Thyroid Nodule Fine-Needle Aspiration in Patients With Initial Benign Cytologic Results
Anatomic Pathology / REPEAT THYROID FINE-NEEDLE ASPIRATION Repeat Thyroid Nodule Fine-Needle Aspiration in Patients With Initial Benign Cytologic Results Melina B. Flanagan, MD, MSPH, 1 N. Paul Ohori,
More informationI mportant prognostic factors in renal cell carcinoma (RCC)
39 ORIGINAL ARTICLE Prognostic relevance of extensive necrosis in renal cell carcinoma V Foria, T Surendra, D N Poller... See end of article for authors affiliations... Correspondence to: Dr D N Poller,
More informationSaturation Biopsy for Diagnosis and Staging and Management of Prostate Cancer
Saturation Biopsy for Diagnosis and Staging and Management of Prostate Cancer Policy Number: 7.01.121 Last Review: 2/2018 Origination: 8/2006 Next Review: 8/2018 Policy Blue Cross and Blue Shield of Kansas
More informationPrediction of complications after partial nephrectomy by RENAL nephrometry score
UROLOGY Ann R Coll Surg Engl 04; 96: 475 479 doi 0.308/00358844X3946849035 Prediction of complications after partial nephrectomy by RENAL nephrometry score UD Reddy, R Pillai, RA Parker, J Weston, NA Burgess,
More informationSalvage surgery after energy ablation for renal masses
Salvage surgery after energy ablation for renal masses Jose A. Karam, Christopher G. Wood, Zachary R. Compton, Priya Rao*, Raghunandan Vikram, Kamran Ahrar and Surena F. Matin Departments of Urology, *Pathology,
More informationSmall renal masses: Toward more rational treatment
REVIEW CME CREDIT EDUCATIONAL OBJECTIVE: Readers will discuss the treatments for small renal masses, including nephron-sparing options ANIL A. THOMAS, MD Glickman Urological and Kidney Institute, Cleveland
More informationComparison of Partial and Radical Nephrectomy for pt1b Renal Cell Carcinoma
www.kjurology.org DOI:10.4111/kju.2010.51.9.596 Urological Oncology Comparison of Partial and Radical Nephrectomy for pt1b Renal Cell Carcinoma Jong Min Kim, Phil Hyun Song, Hyun Tae Kim, Tong Choon Park
More informationJMSCR Vol 06 Issue 02 Page February 2018
www.jmscr.igmpublication.org Impact Factor (SJIF): 6.379 Index Copernicus Value: 71.58 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v6i2.08 Pattern of Renal Tumors: A Tertiary
More informationThe role of Bosniak classification in malignant tumor diagnosis: A single institution experience
Original Article - Urological Oncology http://dx.doi.org/10.4111/icu.2016.57.2.100 pissn 2466-0493 eissn 2466-054X The role of Bosniak classification in malignant tumor diagnosis: A single institution
More informationOwing to the widespread use of prostate specific antigen (PSA)
ORIGINAL RESEARCH Subsequent prostate cancer detection in patients with prostatic intraepithelial neoplasia or atypical small acinar proliferation Moamen M. Amin, MD; Suganthiny Jeyaganth, MSc; Nader Fahmy,
More informationAndrogen Receptor Expression in Renal Cell Carcinoma: A New Actionable Target?
Androgen Receptor Expression in Renal Cell Carcinoma: A New Actionable Target? New Frontiers in Urologic Oncology Juan Chipollini, MD Clinical Fellow Department of Genitourinary Oncology Moffitt Cancer
More information